A comparative study on the effect of Warfarin v/s Acenocoumarol in patients with atrial fibrillation
[...]by rectifying these drawbacks we had conducted this study for a comparatively longer duration on a larger sample size. Inclusion criteria: * All adult patients with age >18 years with confirmed diagnosis of atrial fibrillation. * Patients who were on warfarin and acenocoumarol as anticoagula...
Gespeichert in:
| Veröffentlicht in: | Research journal of pharmacy and technology 2021-01, Vol.14 (1), p.1-5 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 5 |
|---|---|
| container_issue | 1 |
| container_start_page | 1 |
| container_title | Research journal of pharmacy and technology |
| container_volume | 14 |
| creator | Alias, Shilpa Mary Nair, Vishnu S Byju, Parvathy Pai, Praveen G Reghu, Remya |
| description | [...]by rectifying these drawbacks we had conducted this study for a comparatively longer duration on a larger sample size. Inclusion criteria: * All adult patients with age >18 years with confirmed diagnosis of atrial fibrillation. * Patients who were on warfarin and acenocoumarol as anticoagulant therapy. * Patient who were willing to provide information through phone. Statistically significant betterment of QOL was seen in patients with use of acenocoumarol compared to warfarin over a number of domains which are physical functioning (acenocoumarol: 52.98±26.07; warfarin 40.60±30.76, p value 0.002), general health (acenocoumarol 74.31±20.25; warfarin 62.84±31.29, p value 0.002) and mental health (acenocoumarol 79.35±14.16, warfarin 73.67±13.36, p value 0.003). Warfarin group showed statistically significant association between medication adherence and TTR as well as medication adherence and quality of life domains like, physical functioning (40.60%), role physical (13.79%), general health (62.84%) and vitality (67.77%). |
| doi_str_mv | 10.5958/0974-360X.2021.00001.9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2533806051</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2533806051</sourcerecordid><originalsourceid>FETCH-LOGICAL-c145t-afe974027022f20193daf2b7c0616693af72bd143d87551cc1ae3e01e84123f33</originalsourceid><addsrcrecordid>eNo9kMlqwzAQhkVpoSHNKxRBz3a0WLJ8DKEbBHppaW9CkSWi4FiuJKfk7Ss3JXOZYeaf7QPgHqOSNUwsUVNXBeXoqySI4BJlw2VzBWaXwvUlxuIWLGLcTyIuGKnEDLQrqP1hUEEldzQwprE9Qd_DtDPQWGt0gt7CTxWsCq6Hx2WEK216r_14UMF3MCeH3Gv6FOGPSzuoUnCqg9Ztg-u6XPL9Hbixqotm8e_n4OPp8X39Umzenl_Xq02hccVSoazJhyJSI0IsQbihrbJkW2vEMecNVbYm2xZXtBU1Y1hrrAw1CBtRYUItpXPwcJ47BP89mpjk3o-hzyslYZQKxBHDWcXPKh18jMFYOQSXnzlJjOQEVU685MROTlDlH1TZ0F9aXWok</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2533806051</pqid></control><display><type>article</type><title>A comparative study on the effect of Warfarin v/s Acenocoumarol in patients with atrial fibrillation</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Alias, Shilpa Mary ; Nair, Vishnu S ; Byju, Parvathy ; Pai, Praveen G ; Reghu, Remya</creator><creatorcontrib>Alias, Shilpa Mary ; Nair, Vishnu S ; Byju, Parvathy ; Pai, Praveen G ; Reghu, Remya</creatorcontrib><description>[...]by rectifying these drawbacks we had conducted this study for a comparatively longer duration on a larger sample size. Inclusion criteria: * All adult patients with age >18 years with confirmed diagnosis of atrial fibrillation. * Patients who were on warfarin and acenocoumarol as anticoagulant therapy. * Patient who were willing to provide information through phone. Statistically significant betterment of QOL was seen in patients with use of acenocoumarol compared to warfarin over a number of domains which are physical functioning (acenocoumarol: 52.98±26.07; warfarin 40.60±30.76, p value 0.002), general health (acenocoumarol 74.31±20.25; warfarin 62.84±31.29, p value 0.002) and mental health (acenocoumarol 79.35±14.16, warfarin 73.67±13.36, p value 0.003). Warfarin group showed statistically significant association between medication adherence and TTR as well as medication adherence and quality of life domains like, physical functioning (40.60%), role physical (13.79%), general health (62.84%) and vitality (67.77%).</description><identifier>ISSN: 0974-3618</identifier><identifier>EISSN: 0974-360X</identifier><identifier>EISSN: 0974-306X</identifier><identifier>DOI: 10.5958/0974-360X.2021.00001.9</identifier><language>eng</language><publisher>Raipur: A&V Publications</publisher><subject>Age ; Anticoagulants ; Cardiac arrhythmia ; Causality ; Drug therapy ; Patient compliance ; Population ; Quality of life ; Software ; Statistical analysis ; Stroke</subject><ispartof>Research journal of pharmacy and technology, 2021-01, Vol.14 (1), p.1-5</ispartof><rights>Copyright A&V Publications Jan 2021</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Alias, Shilpa Mary</creatorcontrib><creatorcontrib>Nair, Vishnu S</creatorcontrib><creatorcontrib>Byju, Parvathy</creatorcontrib><creatorcontrib>Pai, Praveen G</creatorcontrib><creatorcontrib>Reghu, Remya</creatorcontrib><title>A comparative study on the effect of Warfarin v/s Acenocoumarol in patients with atrial fibrillation</title><title>Research journal of pharmacy and technology</title><description>[...]by rectifying these drawbacks we had conducted this study for a comparatively longer duration on a larger sample size. Inclusion criteria: * All adult patients with age >18 years with confirmed diagnosis of atrial fibrillation. * Patients who were on warfarin and acenocoumarol as anticoagulant therapy. * Patient who were willing to provide information through phone. Statistically significant betterment of QOL was seen in patients with use of acenocoumarol compared to warfarin over a number of domains which are physical functioning (acenocoumarol: 52.98±26.07; warfarin 40.60±30.76, p value 0.002), general health (acenocoumarol 74.31±20.25; warfarin 62.84±31.29, p value 0.002) and mental health (acenocoumarol 79.35±14.16, warfarin 73.67±13.36, p value 0.003). Warfarin group showed statistically significant association between medication adherence and TTR as well as medication adherence and quality of life domains like, physical functioning (40.60%), role physical (13.79%), general health (62.84%) and vitality (67.77%).</description><subject>Age</subject><subject>Anticoagulants</subject><subject>Cardiac arrhythmia</subject><subject>Causality</subject><subject>Drug therapy</subject><subject>Patient compliance</subject><subject>Population</subject><subject>Quality of life</subject><subject>Software</subject><subject>Statistical analysis</subject><subject>Stroke</subject><issn>0974-3618</issn><issn>0974-360X</issn><issn>0974-306X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNo9kMlqwzAQhkVpoSHNKxRBz3a0WLJ8DKEbBHppaW9CkSWi4FiuJKfk7Ss3JXOZYeaf7QPgHqOSNUwsUVNXBeXoqySI4BJlw2VzBWaXwvUlxuIWLGLcTyIuGKnEDLQrqP1hUEEldzQwprE9Qd_DtDPQWGt0gt7CTxWsCq6Hx2WEK216r_14UMF3MCeH3Gv6FOGPSzuoUnCqg9Ztg-u6XPL9Hbixqotm8e_n4OPp8X39Umzenl_Xq02hccVSoazJhyJSI0IsQbihrbJkW2vEMecNVbYm2xZXtBU1Y1hrrAw1CBtRYUItpXPwcJ47BP89mpjk3o-hzyslYZQKxBHDWcXPKh18jMFYOQSXnzlJjOQEVU685MROTlDlH1TZ0F9aXWok</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Alias, Shilpa Mary</creator><creator>Nair, Vishnu S</creator><creator>Byju, Parvathy</creator><creator>Pai, Praveen G</creator><creator>Reghu, Remya</creator><general>A&V Publications</general><scope>AAYXX</scope><scope>CITATION</scope><scope>04Q</scope><scope>04S</scope><scope>04W</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20210101</creationdate><title>A comparative study on the effect of Warfarin v/s Acenocoumarol in patients with atrial fibrillation</title><author>Alias, Shilpa Mary ; Nair, Vishnu S ; Byju, Parvathy ; Pai, Praveen G ; Reghu, Remya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c145t-afe974027022f20193daf2b7c0616693af72bd143d87551cc1ae3e01e84123f33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Age</topic><topic>Anticoagulants</topic><topic>Cardiac arrhythmia</topic><topic>Causality</topic><topic>Drug therapy</topic><topic>Patient compliance</topic><topic>Population</topic><topic>Quality of life</topic><topic>Software</topic><topic>Statistical analysis</topic><topic>Stroke</topic><toplevel>online_resources</toplevel><creatorcontrib>Alias, Shilpa Mary</creatorcontrib><creatorcontrib>Nair, Vishnu S</creatorcontrib><creatorcontrib>Byju, Parvathy</creatorcontrib><creatorcontrib>Pai, Praveen G</creatorcontrib><creatorcontrib>Reghu, Remya</creatorcontrib><collection>CrossRef</collection><collection>India Database</collection><collection>India Database: Business</collection><collection>India Database: Science & Technology</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Research journal of pharmacy and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alias, Shilpa Mary</au><au>Nair, Vishnu S</au><au>Byju, Parvathy</au><au>Pai, Praveen G</au><au>Reghu, Remya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A comparative study on the effect of Warfarin v/s Acenocoumarol in patients with atrial fibrillation</atitle><jtitle>Research journal of pharmacy and technology</jtitle><date>2021-01-01</date><risdate>2021</risdate><volume>14</volume><issue>1</issue><spage>1</spage><epage>5</epage><pages>1-5</pages><issn>0974-3618</issn><eissn>0974-360X</eissn><eissn>0974-306X</eissn><abstract>[...]by rectifying these drawbacks we had conducted this study for a comparatively longer duration on a larger sample size. Inclusion criteria: * All adult patients with age >18 years with confirmed diagnosis of atrial fibrillation. * Patients who were on warfarin and acenocoumarol as anticoagulant therapy. * Patient who were willing to provide information through phone. Statistically significant betterment of QOL was seen in patients with use of acenocoumarol compared to warfarin over a number of domains which are physical functioning (acenocoumarol: 52.98±26.07; warfarin 40.60±30.76, p value 0.002), general health (acenocoumarol 74.31±20.25; warfarin 62.84±31.29, p value 0.002) and mental health (acenocoumarol 79.35±14.16, warfarin 73.67±13.36, p value 0.003). Warfarin group showed statistically significant association between medication adherence and TTR as well as medication adherence and quality of life domains like, physical functioning (40.60%), role physical (13.79%), general health (62.84%) and vitality (67.77%).</abstract><cop>Raipur</cop><pub>A&V Publications</pub><doi>10.5958/0974-360X.2021.00001.9</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0974-3618 |
| ispartof | Research journal of pharmacy and technology, 2021-01, Vol.14 (1), p.1-5 |
| issn | 0974-3618 0974-360X 0974-306X |
| language | eng |
| recordid | cdi_proquest_journals_2533806051 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Age Anticoagulants Cardiac arrhythmia Causality Drug therapy Patient compliance Population Quality of life Software Statistical analysis Stroke |
| title | A comparative study on the effect of Warfarin v/s Acenocoumarol in patients with atrial fibrillation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T10%3A31%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20comparative%20study%20on%20the%20effect%20of%20Warfarin%20v/s%20Acenocoumarol%20in%20patients%20with%20atrial%20fibrillation&rft.jtitle=Research%20journal%20of%20pharmacy%20and%20technology&rft.au=Alias,%20Shilpa%20Mary&rft.date=2021-01-01&rft.volume=14&rft.issue=1&rft.spage=1&rft.epage=5&rft.pages=1-5&rft.issn=0974-3618&rft.eissn=0974-360X&rft_id=info:doi/10.5958/0974-360X.2021.00001.9&rft_dat=%3Cproquest_cross%3E2533806051%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2533806051&rft_id=info:pmid/&rfr_iscdi=true |